--- title: "Navigating the IVDR: Challenges, Opportunities, and a Path to Safer Diagnostics" description: The In Vitro Diagnostic Regulation (IVDR) represents the most significant shift in European diagnostic regulations in decades. With increased evidence requirements, stricter notified body oversight, and economic pressures, the transition from IVDD to IVDR is complex, but manageable with the right strategies. --- [![VarSome](https://landing.varsome.com/hubfs/VarSome_February2020%20Theme/Images/logo.png)](https://varsome.com/) - Editions - [More about VarSome.com](https://varsome.com/varsome-editions/varsome/) - [More about VarSome Premium](https://varsome.com/varsome-editions/varsome-premium/) - [More about VarSome Clinical](https://varsome.com/varsome-editions/varsome-clinical/) - [Learn more about APIs](https://varsome.com/information/varsome-api-info/) - About - Resources - [Library](https://varsome.com/library/) - [Documentation](https://docs.varsome.com/) - [Query types](https://varsome.com/about/examples/) - [IVDR](https://landing.varsome.com/ivdr-whitepaper) - [Germline Classification](https://varsome.com/about/resources/acmg-implementation/) - [Somatic Classification](https://varsome.com/about/resources/amp-implementation/) - Partners - [Distributors](https://varsome.com/distributors/) - [Partners](https://varsome.com/partners/) - [Become a partner](https://landing.varsome.com/become-varsome-partner) - General - [The Company](https://saphetor.com/about/) - [Cite VarSome](https://varsome.com/about/varsome-citations/) - [Link to VarSome](https://varsome.com/how-do-i-create-link-varsome/) - [Contact](https://landing.varsome.com/contact) - [Community](https://varsome.com/community-contributions/) - [Blog](https://blog.varsome.com/) [Sign in](https://varsome.com/sign-in/) [Join](https://varsome.com/sign-up/) WHITE PAPER # Navigating the IVDR: Challenges, Opportunities, and a Path to Safer Diagnostics The *In Vitro* Diagnostic Regulation (IVDR) represents the most significant shift in European diagnostic regulations in decades. With increased evidence requirements, stricter notified body oversight, and economic pressures, the transition from IVDD to IVDR is complex, but manageable with the right strategies. Inside this white paper, you’ll discover: - The key regulatory challenges for manufacturers and laboratories - Strategies for compliance, risk mitigation, and smoother certification - Expert insights on notified body shortages, in-house IVDs, and IVDR implementation ![](https://landing.varsome.com/hubfs/Screenshot%202025-03-18%20at%204.30.13%20PM.png) [![Download Now!](https://no-cache.hubspot.com/cta/default/4384097/2b9ac9d6-167f-4157-91bc-b41841bf16e2.png)](https://cta-redirect.hubspot.com/cta/redirect/4384097/2b9ac9d6-167f-4157-91bc-b41841bf16e2) ### Navigating the IVDR: Challenges, Opportunities, and a Path to Safer Diagnostics [![Download Now!](https://no-cache.hubspot.com/cta/default/4384097/2b9ac9d6-167f-4157-91bc-b41841bf16e2.png)](https://cta-redirect.hubspot.com/cta/redirect/4384097/2b9ac9d6-167f-4157-91bc-b41841bf16e2) ![Contributors](https://landing.varsome.com/hubfs/2-Mar-18-2025-04-06-42-5281-PM.png) ## Contributors [**4Bases**](https://www.4bases.ch) is a Swiss-based company specializing in the development, production, and commercialization of clinically validated diagnostic purpose reagent kits for somatic and germinal analyses in NGS. 4bases is ISO 13485:2021 certified, continuously developing new solutions and addressing evolving regulatory needs. Contact: [info@4bases.ch.](mailto:info@4bases.ch) Learn more: [www.4bases.ch](https://4bases.ch/) [**Platomics**](https://www.platomics.com/) automates regulatory processes and connects IVD manufacturers and laboratories to accelerate compliance and enable innovation. The PlatoX® platform saves time, resources, and costs by digitalizing regulatory work on the basis of intelligent data, not docs Learn more: [www.platomics.com](https://www.platomics.com) [**Veranex**](https://www.veranex.com/) is a global** medtech service provider**, offering regulatory strategy, clinical development, and market access support. They help companies navigate complex regulatory landscapes, including IVDR, to accelerate certification and ensure compliance. Learn more: [www.veranex.com](https://www.veranex.com) [**Saphetor**](http://www.saphetor.com) is the creators of **VarSome**; a platform offering advanced variant interpretation tools for clinical diagnostics and research. **Interested in an IVDR-certified solution for NGS analysis? [Let us know!](https://share.hsforms.com/12fOnjRIsRha4dvwhFFP7uA2lysh)** ![What's Covered?](https://landing.varsome.com/hubfs/featured%20(1).png) ## What's Covered? This white paper provides a detailed breakdown of the IVDR landscape, covering the biggest challenges and how to overcome them: - **Understanding the IVDR shift:** What changed from IVDD and why it matters - **Notified body shortages and certification delays:** How they impact market access and strategies to mitigate risks - **Article 5(5) Compliance requirements for In-House IVDs:** What labs need to do to maintain compliance - **Economic and operational impact:** How IVDR affects costs, resource planning, and business strategy - **EUDAMED and regulatory transparency:** How the European Database on Medical Devices will improve compliance ![IVDR 2.0](https://landing.varsome.com/hubfs/LandingPage/img-side2.png) ## IVDR 2.0 This report also looks ahead to **the future of IVDR**, **"IVDR 2.0"**, discussing the potential refinements to balance regulatory rigour with the need for innovation and accessibility.   ###### Interested in our Solutions? ## Get in touch for a demo and consultation Loading... ## Latest News [See all blog posts](https://blog.varsome.com) ![](https://landing.varsome.com/hubfs/VarSome_February2020%20Theme/Images/logo.png) - VarSome Suite - [VarSome.com](https://saphetor.com/varsome-editions/varsome/) - [VarSome Premium](https://saphetor.com/varsome-editions/varsome-premium/) - [VarSome Clinical](https://saphetor.com/varsome-editions/varsome-clinical/) - [VarSome API](https://varsome.com/information/varsome-api-info/) - System Status - [System Status](http://status.saphetor.com/) - Resources - [Query Examples](https://varsome.com/about/examples/) - [Documentation](https://docs.varsome.com/) - [Help Center](https://docs.varsome.com/en) - [Cite VarSome](https://news.varsome.com/en/cite-varsome-the-human-genomic-variant-search-engine) - The Company - [About Saphetor SA](https://saphetor.com/about/) - [News](https://blog.varsome.com) - [Distributors](https://landing.varsome.com/distributors) - [Contact](https://saphetor.com/contact/) - Legal - [Terms of Use](https://varsome.com/terms/) - [Privacy Policy](https://varsome.com/privacy/) VarSome Suite is brought to you by [Saphetor SA](https://saphetor.com). © 2024 Saphetor SA – All Rights Reserved.